Dow Jones Futures Eye Geopolitical Cues as Trump Signals No Rush for Iran Deal Tesla AI Stocks Attract Attention Indian Equity Markets Wobble as Key Stocks See Mixed Activity NTPC Q4 Net Profit Rises 34 to 10615 Crore Revenue Slips to 5041058 Crore Hormel Foods Considered Among Top HighYield Stocks for Retirement Portfolios Expert View Buy on Dips Strategy May Be Avoided Amid Market Volatility Says HDFC Securities Analyst Zscaler Stock Tumbles on Weak Guidance Sales Reorganization UTMD Q1 2024 Earnings Solid EPS Performance Amidst Cautious Market Reaction HDB Q1 FY2026 Earnings EPS Surpasses Estimates by 073 SPOK Q1 2026 Earnings EPS Misses Estimates by 51 Revenue Data Unavailable WPRT Q1 2026 Earnings BetterthanExpected EPS but Stock Declines APPN Q1 2026 Earnings EPS Surge Beats Estimates by 44 WRB Q1 2026 Earnings Strong EPS Beat Driven by Solid Underwriting and Investment Results Futu Holdings FUTU Slumps 275 as Key Support Levels Come Into Focus Ambiq Micro AMBQ Shows Resilience with 186 Gain as Stock Holds Above Key Support Aurinia Pharmaceuticals AUPH Treads at 1522 as Shares Dip Support and Resistance in Focus First Merchants Corporation Depository Shares FRMEP Holds Steady at 2505 Key Levels in Focus Atossa Therapeutics ATOS Holds Steady Near Support Amid Modest Decline US Government Stake in Quantum Firms Traders Eye IonQ Micron Anduril as Next Candidates ASPN Q1 2026 Earnings EPS Misses Estimates as Losses Narrow but Surprise Negative Diversified Healthcare Trust 5625 Senior Notes 2042 DHCNI Hold Steady Near 1838 Following Modest Uptick QuinStreet Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Gains Core Main Inc CNM Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Penumbra PEN Q1 2026 Earnings EPS Misses Estimates by 245 as Revenue Details Remain Unclear ING Q1 2026 Earnings EPS Beats Estimates by 66 as Net Interest Income Holds Steady Stock Declines VOC Q3 2024 Earnings Trust Reports EPS of 018 Amid Stable Distributions CDP Q1 2026 Earnings EPS Surpasses Estimates with 2 Beat CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue